These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8613366)
1. gamma Interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans. Levitz SM; North EA Infect Immun; 1996 May; 64(5):1595-9. PubMed ID: 8613366 [TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferation and cytokine profiles in human peripheral blood mononuclear cells stimulated by Cryptococcus neoformans. Levitz SM; North EA J Med Vet Mycol; 1997; 35(4):229-36. PubMed ID: 9292418 [TBL] [Abstract][Full Text] [Related]
3. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Levitz SM; Dupont MP; Smail EH Infect Immun; 1994 Jan; 62(1):194-202. PubMed ID: 8262627 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Zhang T; Kawakami K; Qureshi MH; Okamura H; Kurimoto M; Saito A Infect Immun; 1997 Sep; 65(9):3594-9. PubMed ID: 9284124 [TBL] [Abstract][Full Text] [Related]
5. Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans. Retini C; Casadevall A; Pietrella D; Monari C; Palazzetti B; Vecchiarelli A J Immunol; 1999 Feb; 162(3):1618-23. PubMed ID: 9973421 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. Levitz SM; Dupont MP J Clin Invest; 1993 Apr; 91(4):1490-8. PubMed ID: 7682573 [TBL] [Abstract][Full Text] [Related]
7. Antifungal activity of interleukin-2-activated natural killer (NK1.1+) lymphocytes against Candida albicans. Mathews HL; Witek-Janusek L J Med Microbiol; 1998 Nov; 47(11):1007-14. PubMed ID: 9822300 [TBL] [Abstract][Full Text] [Related]
8. NK cells eliminate Cryptococcus neoformans by potentiating the fungicidal activity of macrophages rather than by directly killing them upon stimulation with IL-12 and IL-18. Kawakami K; Koguchi Y; Qureshi MH; Yara S; Kinjo Y; Uezu K; Saito A Microbiol Immunol; 2000; 44(12):1043-50. PubMed ID: 11220678 [TBL] [Abstract][Full Text] [Related]
10. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Levitz SM; Tabuni A; Nong SH; Golenbock DT Infect Immun; 1996 Mar; 64(3):945-51. PubMed ID: 8641805 [TBL] [Abstract][Full Text] [Related]
11. Candida albicans-specific lymphoproliferative and cytokine (IL-4 and IFN-gamma) responses in atopic eczema dermatitis syndrome. Evidence of CD4/CD8 and CD3/CD16+CD56 ratio elevations in vitro. Kosonen J; Luhtala M; Viander M; Kalimo K; Terho EO; Savolainen J Exp Dermatol; 2005 Jul; 14(7):551-8. PubMed ID: 15946244 [TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin (IL)-15 priming on IL-12 and interferon-gamma production by pathogen-stimulated peripheral blood mononuclear cells from human immunodeficiency virus-seropositive and -seronegative donors. Parayath KE; Harrison TS; Levitz SM J Infect Dis; 2000 Feb; 181(2):733-6. PubMed ID: 10669365 [TBL] [Abstract][Full Text] [Related]
13. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033 [TBL] [Abstract][Full Text] [Related]
14. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Lee SM; Suen Y; Chang L; Bruner V; Qian J; Indes J; Knoppel E; van de Ven C; Cairo MS Blood; 1996 Aug; 88(3):945-54. PubMed ID: 8704253 [TBL] [Abstract][Full Text] [Related]
16. Interactions between human natural killer (NK) lymphocytes and yeast cells: human NK cells do not kill Candida albicans, although C. albicans blocks NK lysis of K562 cells. Zunino SJ; Hudig D Infect Immun; 1988 Mar; 56(3):564-9. PubMed ID: 3277914 [TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular mechanisms of IFN-gamma production induced by IL-2 and IL-12 in a human NK cell line. Ye J; Ortaldo JR; Conlon K; Winkler-Pickett R; Young HA J Leukoc Biol; 1995 Aug; 58(2):225-33. PubMed ID: 7643015 [TBL] [Abstract][Full Text] [Related]
18. An early imbalance of interleukin 12 influences the adjuvant effect of mannoproteins of Cryptococcus neoformans. Pietrella D; Lupo P; Bistoni F; Vecchiarelli A Cell Microbiol; 2004 Sep; 6(9):883-91. PubMed ID: 15272868 [TBL] [Abstract][Full Text] [Related]
19. Local and systemic immune response to inactivated Candida albicans in mice. Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818 [TBL] [Abstract][Full Text] [Related]
20. Effects of pulsing procedure of interleukin-12 in combination with interleukin-2 on the activation of peripheral blood lymphocytes derived from patients with hepatocellular carcinoma. Sawayama T; Sakaguchi K; Senoh T; Ohta T; Nishimura M; Takaki A; Tsuji T; Shiratori Y Acta Med Okayama; 2003 Dec; 57(6):285-92. PubMed ID: 14726965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]